Metagenomi Q1 2024 Adj EPS $(1.19) Misses $(0.78) Estimate
Portfolio Pulse from Benzinga Newsdesk
Metagenomi (NASDAQ:MGX) reported a Q1 2024 adjusted EPS loss of $(1.19), missing the consensus estimate of $(0.78) by 52.56%.
May 14, 2024 | 8:39 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Metagenomi reported a larger than expected Q1 2024 loss per share of $(1.19), missing the consensus estimate of $(0.78) by a significant margin.
Missing earnings estimates, especially by a significant margin, typically results in negative investor sentiment and can lead to a decrease in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100